Sign in

CIK 0001601830

  • Large accelerated filer

RECURSION PHARMACEUTICALS, INC.

Sign in to watch
Ticker
RXRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464099738
Phone
+1 385-269-0203
Business address
41S RIO GRANDE STREET, SALT LAKE CITY, UT, 84101
Former names
Recursion Pharmaceuticals, LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$701,222
in 5 filings, $701K under 10b5-1 plans

Net −$701,222. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-07-19 Secora Michael Chief Financial Officer Sale 10b5-1 −1,991 $14.36 $29K 865,922
2023-07-19 Secora Michael Chief Financial Officer Sale 10b5-1 −13,150 $15.36 $202K 852,772
2023-07-19 Secora Michael Chief Financial Officer Sale 10b5-1 −9,859 $16.00 $158K 842,913
2023-07-19 Secora Michael Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −37,500 670,313
2023-07-18 Secora Michael Chief Financial Officer Exercise or conversion 10b5-1 +37,500 $2.22 $83K 855,413
2023-07-18 Secora Michael Chief Financial Officer Sale 10b5-1 −24,500 $13.62 $334K 830,913
2023-07-18 Secora Michael Chief Financial Officer Sale 10b5-1 −500 $14.05 $7K 830,413
2023-07-18 Secora Michael Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −37,500 707,813
2023-07-18 Virani Shafique Chief Business Officer Exercise or conversion 10b5-1 +30,000 $2.22 $67K 173,954
2023-07-18 Virani Shafique Chief Business Officer Sale 10b5-1 −30,000 $13.74 $412K 143,954
2023-07-18 Virani Shafique Chief Business Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −30,000 509,469
2023-07-17 Virani Shafique Chief Business Officer Exercise or conversion 10b5-1 +30,000 $2.22 $67K 173,954
2023-07-17 Virani Shafique Chief Business Officer Sale 10b5-1 −30,000 $11.72 $352K 143,954
2023-07-17 Virani Shafique Chief Business Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −30,000 539,469
2023-07-13 Burrell Terry-Ann Director Sale −8,275 $12.59 $104K 54,847
2023-07-12 Gibson Christopher Chief Executive Officer Exercise or conversion +31,250 $2.48 $78K 947,628
2023-07-12 Gibson Christopher Chief Executive Officer Sale −3,423 $10.87 $37K 944,205
2023-07-12 Gibson Christopher Chief Executive Officer Sale −7,898 $11.80 $93K 936,307
2023-07-12 Gibson Christopher Chief Executive Officer Sale −3,270 $12.39 $41K 933,037
2023-07-12 Gibson Christopher Chief Executive Officer Sale −17,227 $14.34 $247K 915,810

Page 35 of 41 · 805 trades